CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 12.50
+0.75 (6.38%)
Apr 15, 2026, 3:50 PM GMT
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 6.08 million as of April 15, 2026. Its market cap has increased by 95.81% in one year.
Market Cap
6.08M
Enterprise Value
5.73M
Revenue
25.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.50
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 6.08M, a decrease of -78.47%. That is a compound annual growth rate of -7.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 6.08M | 17.50% |
| Dec 31, 2025 | 5.17M | 43.93% |
| Dec 31, 2024 | 3.59M | -74.19% |
| Dec 30, 2022 | 13.93M | -40.80% |
| Dec 31, 2021 | 23.53M | 6.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genflow Biosciences | 11.52M |
| Cizzle Biotechnology Holdings | 9.32M |
| Oxford BioDynamics | 8.15M |
| Futura Medical | 6.92M |
| IXICO | 6.83M |
| OptiBiotix Health | 5.63M |
| Thalia Therapeutics | 5.62M |
| Nuformix | 4.96M |